Canadian ;
As one of the only companies founded, owned, and managed exclusively in Canada, BioJAMP, a division of JAMP Pharma Corporation aims to become the Canadian HCPs partner of choice in the evolution towards biosimilars.

Simplicity ;
BioJAMP is committed to simplifying the collaboration journey to Canadian HCPs and patients. We value a consistent, yet flexible support throughout our portfolio of specialty product offerings, without compromising the efficacy, quality, or safety of our products.

Future ;
BioJAMP is dedicated to the future with our vision to provide Canadians access to a robust portfolio of biosimilars.

At BioJAMP, our mission is to provide value-added biosimilar products that meet the needs of patients and healthcare professionals.

If you want to learn more about BioJAMP, please visit

Are you a dermatologist or a family physician?

Enjoy a complimentary e-subscription to SkinTherapyLetter®, a prestigious Dermatology journal indexed with the National Library in Washington.

Subscribe Today!